AZE 📈 Azelis - Overview
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974400328
AZE: Specialty Chemicals, Food Ingredients, Personal Care Products
Azelis Group NV is a leading global distributor of specialty chemicals and food ingredients, catering to a diverse range of industries. The company's life sciences segment serves various markets, including personal care, home care, and industrial cleaning, where it provides innovative solutions to manufacturers of soaps, detergents, and cleaning products. Additionally, Azelis supplies pharmaceuticals, healthcare, food and nutrition, animal nutrition, and agricultural industries with high-quality chemicals and ingredients, supporting the development of new products and formulations. Its environmental solutions division focuses on sustainable and eco-friendly products, addressing the growing need for environmentally responsible practices.
In the industrial chemicals sector, Azelis Group NV operates in several key markets, including Coatings, Adhesives, Sealants, and Elastomers (CASE), as well as advanced materials and additives. The company also serves the lubricants, metalworking fluids, and electronics industries, providing specialty chemicals and raw materials to manufacturers of automotive, aerospace, and industrial equipment. Furthermore, Azelis supplies essential and fine chemicals to various sectors, including textiles, leather, and paper production. With its extensive product portfolio and deep industry expertise, the company is well-positioned to support its customers' growth and innovation efforts.
Geographically, Azelis Group NV has a strong presence in Europe, the Middle East, and Africa, as well as the Americas and the Asia-Pacific region. This global footprint enables the company to provide localized support to its customers, while also leveraging its international network to source high-quality products and stay ahead of market trends. Founded in 1996 and headquartered in Antwerp, Belgium, Azelis Group NV has established itself as a trusted partner to the specialty chemicals and food ingredients industries, with a proven track record of delivering value to its customers and stakeholders. The company's common stock is listed under the ISIN code BE0974400328 and is classified under the GICS Sub Industry: Specialty Chemicals.
Additional Sources for AZE Stock
AZE Stock Overview
Market Cap in USD | 5,096m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
AZE Stock Ratings
Growth 5y | -56.1% |
Fundamental | 54.6% |
Dividend | 48.8% |
Rel. Strength Industry | -8762 |
Analysts | - |
Fair Price Momentum | 16.91 EUR |
Fair Price DCF | 57.30 EUR |
AZE Dividends
Dividend Yield 12m | 1.16% |
Yield on Cost 5y | 0.81% |
Annual Growth 5y | 115.25% |
Payout Consistency | 100.0% |
AZE Growth Ratios
Growth Correlation 3m | -20.8% |
Growth Correlation 12m | -24.9% |
Growth Correlation 5y | -66.5% |
CAGR 5y | -10.38% |
CAGR/Mean DD 5y | -0.44 |
Sharpe Ratio 12m | -0.47 |
Alpha | -29.32 |
Beta | 0.45 |
Volatility | 33.62% |
Current Volume | 539.9k |
Average Volume 20d | 572.3k |
As of December 21, 2024, the stock is trading at EUR 18.86 with a total of 539,932 shares traded.
Over the past week, the price has changed by -3.61%, over one month by +2.99%, over three months by -1.30% and over the past year by -13.08%.
Partly, yes. Based on ValueRay Fundamental Analyses, Azelis (BR:AZE) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.57 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZE as of December 2024 is 16.91. This means that AZE is currently overvalued and has a potential downside of -10.34%.
Azelis has no consensus analysts rating.
According to ValueRays Forecast Model, AZE Azelis will be worth about 18.4 in December 2025. The stock is currently trading at 18.86. This means that the stock has a potential downside of -2.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 25.1 | 33.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 18.4 | -2.7% |